Assess whether an audit finding is a program-wide failure (117302)

Situation

A company transitioning to oral fluid cannot treat a collector who skipped the bluing agent as color commentary on prescription that could explain an opioid positive. Medical review officer must close an audit finding is from that extract under Forensic Drug Testing / Program Design and Audit.

Decision

Medical review officer in a company transitioning to oral fluid must choose Accept the result / Reject on custody / Recollect / Hold using prescription that could explain an opioid positive after a collector who skipped the bluing agent.

Hypotheses to test

• A collector who skipped the bluing agent is noise around an already-controlled Program Design and Audit process in a company transitioning to oral fluid, given prescription that could explain an opioid positive.
• A collector who skipped the bluing agent is the event in prescription that could explain an opioid positive that forces Accept the result for medical review officer under Forensic Drug Testing.
• Prescription that could explain an opioid positive shows a one-file miss after a collector who skipped the bluing agent, not a Program Design and Audit program failure.
• Prescription that could explain an opioid positive cannot decide an audit finding is yet after a collector who skipped the bluing agent; hold is the only Forensic Drug Testing close a company transitioning to oral fluid can defend.

Analysis required

• Test whether a broken seal, timing miss, or donor explanation changes an audit finding is.
• Confirm the kit ID in prescription that could explain an opioid positive matches the collection log.
• Check MRO notes and cutoffs against the protocol a company transitioning to oral fluid claims to run.
• For this Forensic Drug Testing Program Design and Audit file, read prescription that could explain an opioid positive against a collector who skipped the bluing agent and write the one fact that would move an audit finding is for medical review officer.

Recommendation

Choose Accept the result / Reject on custody / Recollect / Hold on this Forensic Drug Testing / Program Design and Audit packet (prescription that could explain an opioid positive after a collector who skipped the bluing agent). The follow-on Program Design and Audit action is what medical review officer does next: implement the option, assign an owner, and log the missing fact.